Shanghai Pharmaceuticals Holding Co. Ltd. Class ASSE: 601607

Announcement on the Receipt of Clinical Trial Approval Notice for Qiling Granules

· Issued by Shanghai Pharmaceuticals Holding Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on the Receipt of Clinical Trial Approval Notice for Qiling Granules

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment